Abstract
Several management options are available to patients with stage I seminoma, including adjuvant radiotherapy, surveillance, and adjuvant chemotherapy. We performed a pooled analysis of patients from the four largest surveillance studies to better delineate prognostic factors associated with disease progression.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Clinical Oncology |
| Vol/bind | 20 |
| Udgave nummer | 22 |
| Sider (fra-til) | 4448-52 |
| Antal sider | 5 |
| ISSN | 0732-183X |
| Status | Udgivet - 15 nov. 2002 |